Theodore James Washburn Jr. insider trades: Agios Pharmaceuticals (AGIO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Theodore reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | AGIO | ↓ Sell | 5,272 | $28.88 | $152K | Direct | Mar 5, 2026 (2d) |
| Sep 5, 2025 | AGIO | ↓ Sell | 8,546 | $36.87 | $315K | Direct | Sep 9, 2025 (4d) |
| Mar 3, 2025 | AGIO | ↓ Sell | 1,655 | $35.54 | $59K | Direct | Mar 4, 2025 (1d) |
| Feb 5, 2025 | AGIO | ↓ Sell | 2,272 | $34.39 | $78K | Direct | Feb 5, 2025 (0d) |
| Nov 8, 2024 | AGIO | ↓ Sell | 772 | $56.09 | $43K | Direct | Nov 13, 2024 (5d) |
| Jun 3, 2024 | AGIO | ↓ Sell | 1,362 | $44.39 | $60K | Direct | Jun 5, 2024 (2d) |
| Mar 5, 2024 | AGIO | ↓ Sell | 1,913 | $31.75 | $61K | Direct | Mar 7, 2024 (2d) |
| Mar 5, 2024 | AGIO | ↓ Sell | 1,214 | $32.57 | $40K | Direct | Mar 5, 2024 (0d) |
| Feb 20, 2024 | AGIO | ↓ Sell | 504 | $26.63 | $13K | Direct | Feb 22, 2024 (2d) |
| Feb 14, 2024 | AGIO | ↓ Sell | 273 | $25.14 | $7K | Direct | Feb 14, 2024 (0d) |
| Aug 7, 2023 | AGIO | ↓ Sell | 2,918 | $25.39 | $74K | Direct | Aug 9, 2023 (2d) |
| Aug 1, 2023 | AGIO | ↓ Sell | 1,232 | $26.26 | $32K | Direct | Aug 2, 2023 (1d) |
| Mar 3, 2023 | AGIO | ↓ Sell | 504 | $24.29 | $12K | Direct | Mar 7, 2023 (4d) |
| Feb 16, 2023 | AGIO | ↓ Sell | 233 | $27.21 | $6K | Direct | Feb 21, 2023 (5d) |
| Feb 14, 2023 | AGIO | ↓ Sell | 504 | $28.59 | $14K | Direct | Feb 16, 2023 (2d) |
| Feb 25, 2022 | AGIO | ↓ Sell | 108 | $30.00 | $3K | Direct | Mar 1, 2022 (4d) |
| Feb 16, 2022 | AGIO | ↓ Sell | 233 | $30.81 | $7K | Direct | Feb 18, 2022 (2d) |
| Feb 14, 2022 | AGIO | ↓ Sell | 504 | $31.25 | $16K | Direct | Feb 16, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AGIO insiders
Open-market trades in the last 12 months
About Theodore James Washburn Jr.'s insider trades
Theodore James Washburn Jr. is Principal Accounting Officer at Agios Pharmaceuticals (AGIO). Since Feb 14, 2022, Theodore has reported no open-market purchases and 18 sales worth $994K on SEC Form 4. In the last 12 months: 1 sale ($152K).
Their filings also include option exercises (11 filings), shares withheld for taxes (6 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.